Nickel-Catalyzed Carbon−Carbon Bond-Forming Reactions of Unactivated Tertiary Alkyl Halides: Suzuki Arylations by Zultanski, Susan L. & Fu, Gregory C.
 S–1 
Nickel-Catalyzed Carbon–Carbon Bond-Forming Reactions 
of Unactivated Tertiary Alkyl Halides: Suzuki Arylations 
 
Susan L. Zultanski†‡ and Gregory C. Fu†‡* 
 †Department of Chemistry, Massachusetts Institute of Technology, 
Cambridge, Massachusetts 02139, United States ‡Division of Chemistry and Chemical Engineering, California Institute of Technology, 
Pasadena, California 91125, United States 
 
Supporting Information 
 
Table of Contents 
 
I. General Information S–1 
II. Preparation of Electrophiles S–2 
III. Preparation of Nucleophiles S–2 
IV. Suzuki Cross-Couplings of Unactivated Tertiary Alkyl Halides S–4 
V. Examples of Recalcitrant Aryl-(9-BBN) Coupling Partners S–11 
VI. 1H NMR Spectra S–12 
 
 
I.  General Information 
 
The following reagents were purchased and used as received: NiBr2• diglyme (Aldrich; note: 
hygroscopic), 4,4’-di-t-butyl-2,2’-bipyridine (Aldrich), LiOt-Bu (Aldrich, 97%; Strem, 98%), i-
BuOH (Aldrich; anhydrous), benzene (Aldrich; anhydrous), 2-bromo-2-methylpropane 
(Aldrich), and 2-chloro-2-methylpropane (Aldrich).  Other tertiary alkyl bromides were 
prepared from the corresponding alcohols, using LiBr and HBr.1 
All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen.  
GC analyses were obtained on an HP 6890 Series GC system with a DB-1 column (length 30 m, 
internal diameter 0.25 mm). 
 
 
                                                
(1) Masada, H.; Murotani, Y. Bull. Chem. Soc. Jpn. 1980, 53, 1181−1182. 
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II.  Preparation of Electrophiles 
 
The procedure and the yield have not been optimized. 
 
n -Pentyl
Br  
1-Bromo-1-pentylcyclobutane.  This compound was prepared according to a published 
method, starting with 1-pentylcyclobutanol (71.3 mmol).2  The product was distilled at 73 °C at 
20 Torr.  Colorless oil (10.6 g, 73%). 
1H NMR (400 MHz, CDCl3) ! 2.67–2.60 (m, 2H), 2.38–2.31 (m, 2H), 2.20–2.09 (m, 1H), 1.87–
1.77 (m, 3H), 1.49–1.42 (m, 2H), 1.35–1.25 (m, 4H), 0.87 (t, 3H, J = 8.0 Hz). 
13C NMR (100 MHz, CDCl3) ! 69.0, 44.1, 40.1, 31.6, 25.8, 22.6, 17.1, 14.1. 
FT-IR (film) 2932, 2859, 1466, 1240, 1140, 856, 424, 407 cm–1. 
MS (EI) m/z (M+) calcd for C9H17Br: 204, 206, found: 204, 206. 
 
 
III.  Preparation of Nucleophiles 
 
The procedures and the yields have not been optimized. 
Whereas we routinely purified the aryl-(9-BBN) reagents by distillation, we have determined 
that the reagents can be used without purification by distillation, at the expense of an ~10% 
reduction in yield in the cross-coupling reaction. 
 
General Procedure for the synthesis of non-commercially available arylmagnesium 
bromides.  Magnesium turnings (417 mg, 17.2 mmol, 1.1 equiv) and a crystal of iodine were 
added to a flame-dried two-neck round-bottom flask under a positive pressure of nitrogen.  The 
magnesium turnings and iodine were allowed to stir under nitrogen for 2 h.  THF (anhydrous; 
20 mL) was added, and the mixture was allowed to stir until the iodine color disappeared (this 
can be assisted by gentle heating with a heat gun).  A solution of the aryl bromide (17.2 mmol) 
in anhydrous THF (4 mL) was then added dropwise over 5 min.  The mixture was stirred at 40 
°C for 3 h.  The reaction was then titrated according to a literature procedure,3 and the Grignard 
reagent was used directly in the synthesis of the corresponding aryl-(9-BBN) reagent. 
General Procedure for the synthesis of aryl-(9-BBN) reagents from arylmagnesium 
bromides.  The aryl-(9-BBN) reagents were prepared by following a literature procedure for the 
synthesis of phenyl-(9-BBN) via the reaction of phenylmagnesium bromide with B-methoxy-(9-
BBN) (Aldrich; 1.0 M in hexanes).4 
(m-Tolyl)-(9-BBN) was also prepared according to a literature procedure.5 
 
                                                
(2) Leroux, Y.; Normant, H. Compt. Rend. 1967, 265, 1472−1474. 
(3) Krasovskiy, A.; Knochel, P. Synthesis 2006, 5, 890−891. 
(4) Fang, G. Y.; Wallner, O. A.; Di Blasio, N.; Ginesta, X.; Harvey, J. N.; Aggarwal, V. K. J. Am. 
Chem. Soc. 2007, 129, 14632−14639. 
(5) Lundin, P. M.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 11027−11029. 
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(9-BBN)
i -Pr
 
 (1s,5s)-9-(3-Isopropylphenyl)-9-borabicyclo[3.3.1]nonane.  The title compound was 
prepared from 3-(isopropylphenyl)magnesium bromide (25.1 mmol).  The product was distilled 
at 96°C at 100 mTorr.  Colorless oil (3.2 g, 13.4 mmol, 53%). 
1H NMR (400 MHz, CDCl3) ! 7.96−7.91 (m, 2H), 7.57−7.50 (m, 2H), 3.10 (sept, 1H, J = 6.7 Hz), 
2.44−2.42 (m, 2H), 2.18−2.06 (m, 6H), 2.00−1.91 (m, 4H), 1.43 (d, 6H, J = 8.0 Hz), 1.49−1.36 (m, 
2H). 
13C NMR (100 MHz, CDCl3) ! 148.3, 132.8, 132.3, 131.0, 128.1, 34.4, 34.3, 29.3, 24.2, 23.6. 
11B NMR (128 MHz, CDCl3) ! 80. 
 
 
 
(9-BBN)
Ph
 
(1s,5s)-9-([1,1'-Biphenyl]-3-yl)-9-borabicyclo[3.3.1]nonane.  The title compound was 
prepared from [1,1'-biphenyl]-3-ylmagnesium bromide (21.4 mmol).  The product was distilled 
at 135 °C at 150 mTorr.  Colorless oil (1.7 g, 6.3 mmol, 29%). 
1H NMR (400 MHz, CDCl3) ! 8.22−8.21 (m, 1H), 8.00−7.98 (m, 1H), 7.83−7.80 (m, 1H), 
7.68−7.50 (m, 3H), 7.49−7.41 (m, 2H), 7.40−7.37 (m, 1H), 2.40−2.37 (m, 2H), 2.11−1.98 (m, 6H), 
1.93−1.83 (m, 4H), 1.41−1.33 (m, 2H). 
13C NMR (400 MHz, CDCl3) ! 141.4, 140.9, 133.5, 133.4, 131.6, 128.8, 128.5, 127.32, 127.26, 34.2, 
29.4, 23.5. 
11B NMR (400 MHz, CDCl3) ! 80. 
 
 
(9-BBN)
OTBS
 
(3-((1s,5s)-9-Borabicyclo[3.3.1]nonan-9-yl)phenoxy)(tert-butyl)dimethylsilane.  The title 
compound was prepared from (3-((tert-butyldimethylsilyl)oxy)phenyl)magnesium bromide 
(19.4 mmol).  The literature procedure was modified as follows: after (3-((tert-
butyldimethylsilyl)oxy)phenyl)magnesium bromide was added to the solution of B-methoxy-(9-
BBN) in diethyl ether, the resulting mixture was stirred for 48 h before continuing to the next 
step of the reaction.  The product was distilled at 165 °C at 500 mTorr.  Colorless oil (2.0 g, 6.1 
mmol, 31%). 
1H NMR (400 MHz, CDCl3) ! 7.62−7.57 (m, 1H), 7.46−7.43 (m, 1H), 7.38−7.34 (m, 1H), 
7.08−7.04 (m, 1H), 2.28−2.25 (m, 2H), 2.07−1.96 (m, 6H), 1.88−1.80 (m, 4H), 1.38−1.31 (m, 2H), 
1.03 (s, 9H), 0.24 (s, 6H). 
13C NMR (100 MHz, CDCl3) ! 155.5, 129.0, 127.5, 125.6, 124.4, 34.2, 29.4, 25.8, 23.5, 18.3, 4.3. 
11B NMR (128 MHz, CDCl3) ! 81. 
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(9-BBN)
Oi -Pr
 
 (1s,5s)-9-(3-Isopropoxyphenyl)-9-borabicyclo[3.3.1]nonane.  The title compound was 
prepared from 3-(isopropoxyphenyl)magnesium bromide, 23.0 mmol (The literature procedure 
was modified as follows: Once 3-(isopropoxyphenyl)magnesium bromide was added to the 
solution of B-methoxy-(9-BBN) in diethyl ether, the resulting mixture was stirred for 48 h before 
continuing to the next step of the reaction).  The product was distilled at 124°C at 510 mTorr.  
Colorless oil (2.5 g, 8.3 mmol, 36%). 
1H NMR (400 MHz, CDCl3) ! 7.60−7.58 (m, 1H), 7.55−7.54 (m, 1H), 7.43 (t, 1H, J = 8.0 Hz), 
7.15−7.12 (m, 1H), 4.67 (sept, 1H, J = 6.0 Hz), 2.32−2.30 (m, 2H), 2.15−2.04 (m, 6H), 1.92−1.86 (m, 
4H), 1.42 (d, 6H, J = 4.0 Hz), 1.38−1.32 (m, 2H). 
13C NMR (100 MHz, CDCl3) ! 157.7, 129.1, 126.8, 121.8, 120.0, 69.7, 34.2, 29.4, 23.5, 22.1. 
11B NMR (128 MHz, CDCl3) ! 81. 
 
 
IV.  Suzuki Cross-Couplings of Unactivated Tertiary Alkyl Halides 
 
For a glovebox-free procedure, see below. 
General Procedure for the activation of aryl-(9-BBN) reagents.  In a nitrogen-filled 
glovebox, the aryl-9-BBN reagent (2.50 mmol, 2.5 equiv) was added to a slurry of LiOt-Bu (192 
mg, 2.40 mmol, 2.4 equiv), i-BuOH (178 mg, 222 "L, 2.40 mmol, 2.4 equiv), and benzene (1.0 mL) 
in a 4-mL vial equipped with a magnetic stir bar.  The vial was sealed with a PTFE-lined septum 
cap, and the mixture was stirred vigorously for 20 min and used immediately in the subsequent 
cross-coupling reaction. 
General Procedure A (Table 2 and eq 4–6).  In a nitrogen-filled glovebox, NiBr2• diglyme 
(35.5 mg, 0.10 mmol, 0.10 equiv) and 4,4’-di-t-butyl-2,2’-bipyridine (30.0 mg, 0.11 mmol, 0.11 
equiv) were added to a 30-mL vial equipped with a magnetic stir bar.  Benzene (anhydrous; 24 
mL) was added, the vial was sealed with a PTFE-lined cap, and the resulting mixture was 
stirred vigorously for 2 h (a light-green slurry formed).  The solution of the activated aryl-(9-
BBN) reagent was then added to the slurry, and the reaction vial was sealed with a PTFE-lined 
cap and stirred for 20 min (the reaction mixture turned dark-green).  The tertiary alkyl halide 
(neat; 1.0 mmol, 1.0 equiv) was then added to the slurry via microsyringe.  The resulting 
mixture was capped and stirred vigorously at 40 °C for 24 h (outside of the glovebox).  Next, the 
reaction mixture was filtered through a plug of silica gel, which was rinsed with diethyl ether, 
and the filtrate was concentrated using rotary evaporation.  The product was purified by 
chromatography. 
General Procedure B (Table 3).  General procedure A was followed, except that the reaction 
was heated to 60 °C, instead of 40 °C. 
General Procedure C (1-iodoadamantane; eq 3).  General procedure A was followed, except 
that cyclohexane (anhydrous; 1.0 mL) was used in place of benzene for the activation of the aryl-
(9-BBN) and that cyclohexane (5.7 mL) was used in place of benzene for the cross-coupling. 
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Glovebox-free procedure: Cross-coupling of phenyl-(9-BBN) with 1-bromo-1-
methylcyclohexane.  A 250-mL two-neck round-bottom flask equipped with a stir bar was 
connected to the outer joint of a swivel frit, and the outer joint on the other end of the swivel frit 
was connected to a 250-mL one-neck round-bottom flask, also equipped with a stir bar.  The 
swivel frit was connected to a high-vacuum line, and the entire apparatus was flame-dried 
under vacuum.  The apparatus was allowed to cool under vacuum overnight.  In the two-neck 
flask, phenyl-(9-BBN) was synthesized according the literature procedure (10 mmol scale).4  At 
the end of the reaction, the mixture of phenyl-(9-BBN), magnesium salts, and hexanes was 
filtered into the 250-mL one-neck flask using the swivel frit under a gentle vacuum, to give a 
clear solution of phenyl-(9-BBN) in hexanes.  The hexanes were removed under high vacuum, 
and the resulting phenyl-(9-BBN) was dried under vacuum for 1 h. 
A 25-mL two-neck pear-shaped Schlenk flask equipped with a stir bar was flame-dried 
under high vacuum and then allowed to cool to room temperature.  Under a positive 
atmosphere of nitrogen, LiOt-Bu (192 mg, 2.40 mmol, 2.4 equiv) was added, and the flask was 
capped and then placed under high vacuum for 30 min.  Under an atmosphere of nitrogen, i-
BuOH (anhydrous; 178 mg, 222 "L, 2.40 mmol, 2.4 equiv), freshly synthesized phenyl-(9-BBN) 
(density = 1.0 g/mL; 495 mg, 2.5 mmol, 2.5 equiv), and benzene (anhydrous; 1.0 mL) were 
added to the flask, which was subsequently purged with nitrogen for 5 min.  The resulting 
cloudy mixture was allowed to stir for 20 min. 
A 100-mL two-neck round-bottom Schlenk flask equipped with a stir bar was flame-dried 
under high vacuum and allowed to cool to room temperature.  Under a positive atmosphere of 
nitrogen, NiBr2• diglyme (35.5 mg, 0.10 mmol, 0.10 equiv) and 4,4’-di-t-butyl-2,2’-bipyridine 
(30.0 mg, 0.11 mmol, 0.11 equiv) were added, and the flask was capped and then placed under 
high vacuum, with stirring, for 30 min.  Under an atmosphere of nitrogen, benzene (anhydrous; 
24 mL) was added to the flask, which was then purged with nitrogen for 5 min.  This 
nickel/ligand mixture was allowed to stir at room temperature for 2 h (light-green slurry).  The 
activated phenyl-(9-BBN) was then transferred via syringe to the nickel/ligand slurry, and the 
resulting mixture was allowed to stir for 20 min (dark-green reaction mixture).  Then, neat 1-
bromo-1-methylcyclohexane (177 mg, 1.0 mmol) was added to the reaction mixture, which was 
purged with nitrogen for 5 min and then heated to 40 °C for 24 h.  Next, pentadecane (internal 
standard to obtain a calibrated yield by GC; 100 µL) was added to the mixture, and the reaction 
mixture was filtered through a plug of silica, rinsing with diethyl ether.  The filtrate was 
concentrated using rotary evaporation.  GC analysis revealed a yield of 70%.  The yield of a 
corresponding reaction, set up in a glovebox with non-distilled phenyl-(9-BBN), was 76%. 
 
 
Me
Ph  
(1-Methylcyclohexyl)benzene [828-45-5] (Table 2, entry 1).  The title compound was 
prepared according to general procedure A, using 1-bromo-1-methylcyclohexane (177 mg, 1.0 
mmol) and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  
Colorless oil. 
First run: 148 mg (85%).  Second run: 144 mg (83%). 
On a larger scale: 1-bromo-1-methylcyclohexane (5.65 mmol): 807 mg (82%). 
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Me Ph
Me Me
 
tert-Butylbenzene [98-06-6] (Table 2, entry 2).  The title compound was prepared according 
to general procedure A, using 2-bromo-2-methylpropane (Aldrich; 112 µL, 1.0 mmol) and 
phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  Colorless oil. 
First run: 94 mg (70%); yield according to GC: 86%.  Second run: 97 mg (72%); yield 
according to GC: 82%.  The product is volatile. 
 
 
Et Ph
Et Et
 
(3-Ethylpentan-3-yl)benzene [4170-84-7] (Table 2, entry 3).  The title compound was 
prepared according to general procedure A, using 3-bromo-3-ethylpentane (179 mg, 1.0 mmol) 
and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  Colorless 
oil. 
First run: 126 mg (72%).  Second run: 119 mg (68%). 
 
 
n-Pentyl
Ph  
(1-Pentylcyclobutyl)benzene (Table 2, entry 4).  The title compound was prepared 
according to general procedure A, using 1-bromo-1-pentylcyclobutane (205 mg, 1.0 mmol) and 
phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  Colorless oil. 
First run: 105 mg (52%).  Second run: 113 mg (54%). 
1H NMR (300 MHz, CDCl3) ! 7.28–7.25 (m, 2H), 7.18–7.09 (m, 3H), 2.40–2.31 (m, 2H), 2.17–
2.03 (m, 3H), 1.86–1.72 (m, 3H), 1.27–1.12 (m, 4H), 1.06–0.98 (m, 2H), 0.82 (t, 3H, J = 6.0 Hz). 
13C NMR (100 MHz, CDCl3) ! 150.7, 127.7, 125.7, 124.9, 46.5, 42.7, 32.8, 32.3, 24.2, 22.6, 16.0, 
14.1. 
FT-IR (film) 3024, 2928, 2856, 1601, 1495, 1466, 1446, 764, 700, 563, 419, 410 cm–1. 
MS (EI) m/z (M+) calcd for C15H22: 202, found: 202. 
 
 
Ph
Me Me
Ph  
(3-Methylbutane-1,3-diyl)dibenzene [1520-43-0] (Table 2, entry 5).  The title compound was 
prepared according to general procedure A, using (3-bromo-3-methylbutyl)benzene (227 mg, 1.0 
mmol) and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  
Colorless oil. 
First run: 195 mg (87%).  Second run: 190 mg (85%). 
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O Me
Ph  
4-Methyl-4-phenyltetrahydro-2H-pyran [67768-01-8] (Table 2, entry 6).  The title compound 
was prepared according to general procedure A, using 4-bromo-4-methyltetrahydro-2H-pyran 
(179 mg, 1.0 mmol) and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, reverse-
phase silica (C-18), 40% → 100% acetonitrile/water, followed by Biotage, silica, 10% → 80% 
Et2O/hexanes.  Colorless oil. 
First run: 102 mg (58%).  Second run: 97 mg (55%). 
 
 
Ph
Me Me
Me
Me
 
(2,6-Dimethylhept-5-en-2-yl)benzene (Table 2, entry 7).  The title compound was prepared 
according to general procedure A, using 6-bromo-2,6-dimethylhept-2-ene (205 mg, 1.0 mmol) 
and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  Colorless 
oil. 
First run: 151 mg (75%).  Second run: 155 mg (77%). 
1H NMR (300 MHz, CDCl3) ! 7.28–7.23 (m, 4H), 7.16–7.14 (m, 1H), 5.04 (t, 1H, J = 8.0 Hz), 
1.75–1.69 (m, 2H), 1.65–1.63 (m, 5H), 1.48 (s, 3H), 1.31 (s, 6H). 
13C NMR (100 MHz, CDCl3) ! 149.4, 131.1, 128.0, 125.9, 125.4, 124.9, 44.6, 37.7, 28.9, 25.7, 23.6, 
17.5. 
FT-IR (film) 2965, 2926, 1496, 1446, 1385, 1366, 764, 699 cm–1. 
MS (EI) m/z (M+) calcd for C15H22: 202, found: 202. 
 
 
Ph
Me Me
Cl  
(6-Chloro-2-methylhexan-2-yl)benzene (Table 2, entry 8).  The title compound was 
prepared according to general procedure A, using 5-bromo-1-chloro-5-methylhexane (214 mg, 
1.0 mmol) and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  
Colorless oil. 
First run: 140 mg (67%).  Second run: 141 mg (67%). 
1H NMR (300 MHz, CDCl3) ! 7.34–7.28 (m, 4H), 7.19–7.17 (m, 1H), 3.44 (t, 2H, J = 8.0 Hz), 
1.71–1.60 (m, 4H), 1.31 (s, 6H), 1.24–1.18 (m, 2H). 
13C NMR (100 MHz, CDCl3) ! 149.2, 128.1, 125.8, 125.5, 44.9, 43.8, 37.7, 33.3, 28.9, 22.2. 
FT-IR (film) 2961, 2868, 1497, 1445, 1387, 1367, 1311, 1031, 765, 700, 652, 569 cm–1. 
MS (EI) m/z (M+) calcd for C13H19Cl: 210, found: 210. 
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Me
Me
 
1-Methyl-3-(1-methylcyclohexyl)benzene [14962-11-9] (Table 3, entry 1).  The title 
compound was prepared according to general procedure B, using 1-bromo-1-
methylcyclohexane (177 mg, 1.0 mmol) and (1s,5s)-9-(m-tolyl)-9-borabicyclo[3.3.1]nonane (530 
mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  Colorless oil. 
First run: 112 mg (60%).  Second run: 115 mg (61%). 
 
 
i -Pr
Me
 
1-Isopropyl-3-(1-methylcyclohexyl)benzene [14962-14-2] (Table 3, entry 2).  The title 
compound was prepared according to general procedure B, using 1-bromo-1-
methylcyclohexane (177 mg, 1.0 mmol) and (1s,5s)-9-(3-isopropylphenyl)-9-
borabicyclo[3.3.1]nonane (601 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  
Colorless oil. 
First run: 134 mg (62%).  Second run: 127 mg (59%). 
 
 
Ph
Me
 
3-(1-Methylcyclohexyl)-1,1'-biphenyl (Table 3, entry 3).  The title compound was prepared 
according to general procedure B, using 1-bromo-1-methylcyclohexane (177 mg, 1.0 mmol) and 
(1s,5s)-9-([1,1'-biphenyl]-3-yl)-9-borabicyclo[3.3.1]nonane (686 mg, 2.5 mmol).  Purification: 
Biotage, reverse-phase silica (C-18), 40% → 100% acetonitrile/water.  Colorless oil. 
First run: 183 mg (73%).  Second run: 187 mg (75%). 
1H NMR (300 MHz, CDCl3) ! 7.64–7.60 (m, 3H), 7.49–7.33 (m, 6H), 2.13–2.05 (m, 2H), 1.70–
1.44 (m, 8H), 1.26 (s, 3H). 
13C NMR (100 MHz, CDCl3) ! 150.5, 142.0, 141.1, 128.7, 128.6, 127.3, 127.1, 125.0, 124.9, 124.2, 
38.1, 38.0, 30.6, 26.4, 22.7. 
FT-IR (film) 3029, 2929, 2856, 1598, 1481, 1466, 1449, 1410, 1075, 894, 798, 756 cm–1. 
MS (EI) m/z (M+) calcd for C19H22: 250, found: 250. 
 
 
 S–9 
OTBS
Me
 
tert-Butyldimethyl(3-(1-methylcyclohexyl)phenoxy)silane (Table 3, entry 4).  The title 
compound was prepared according to general procedure B, using 1-bromo-1-
methylcyclohexane (177 mg, 1.0 mmol) and (3-((1s,5s)-9-borabicyclo[3.3.1]nonan-9-
yl)phenoxy)(tert-butyl)dimethylsilane (821 mg, 2.5 mmol).  Purification: Biotage, reverse-phase 
silica (C-18), 40% → 100% acetonitrile/water.  Colorless oil. 
First run: 164 mg (54%).  Second run: 161 mg (53%). 
1H NMR (300 MHz, CDCl3) ! 6.96 (t, 1H, J = 12.0 Hz), 6.78–6.75 (m, 1H), 6.65 (t, 1H, J = 3.0 
Hz), 6.47–6.43 (m, 1H), 1.80–1.72 (m, 2H), 1.37–1.22 (m, 8H), 0.96 (s, 3H), 0.79 (s, 9H), 0.00 (s, 6H). 
13C NMR (100 MHz, CDCl3) ! 170.0, 155.5, 128.9, 118.8, 118.0, 116.8, 37.9, 37.9, 30.5, 26.4, 25.8, 
22.7, 18.3, 4.4. 
FT-IR (film) 2929, 2858, 1600, 1581, 1487, 1472, 1361, 1302, 1251, 1190, 1002, 981, 953, 874, 835, 
781 cm–1. 
MS (EI) m/z (M+) calcd for C19H32OSi: 304, found: 304. 
 
 
Oi -Pr
Me
 
1-Isopropoxy-3-(1-methylcyclohexyl)benzene (Table 3, entry 5).  The title compound was 
prepared according to general procedure B, using 1-bromo-1-methylcyclohexane (177 mg, 1.0 
mmol) and (1s,5s)-9-(3-isopropoxyphenyl)-9-borabicyclo[3.3.1]nonane (641 mg, 2.5 mmol).  
Purification: Biotage, reverse-phase silica (C-18), 40% → 100% acetonitrile/water.  Colorless oil. 
First run: 133 mg (57%).  Second run: 130 mg (56%). 
1H NMR (300 MHz, CDCl3) ! 7.25–7.20 (m, 1H), 6.98–6.91 (m, 2H), 6.73–6.69 (m, 1H), 4.60–
4.51 (m, 1H), 2.02–1.95 (m, 2H), 1.59–1.42 (m, 8H), 1.35 (d, 6H, J = 9.0 Hz), 1.18 (s, 3H). 
13C NMR (100 MHz, CDCl3) ! 157.8, 152.0, 128.9, 118.2, 114.6, 111.7, 69.6, 38.0, 37.9, 30.5, 26.4, 
22.7, 22.2. 
FT-IR (film) 2975, 2930, 2857, 1605, 1579, 1487, 1467, 1452, 1383, 1372, 1289, 1239, 1188, 1122, 
1000, 985, 961, 873, 773 cm–1. 
MS (EI) m/z (M+) calcd for C16H24O: 232, found: 232. 
 
 
Ph  
(3r,5r,7r)-1-Phenyladamantane [780-68-7] (eq 3).  The title compound was prepared 
according to general procedure C, using 1-iodoadamantane (262 mg, 1.0 mmol) and phenyl-(9-
BBN) (495 mg, 2.5 mmol).  Purification: Biotage, silica, 100% hexanes.  White solid. 
First run: 157 mg (74%).  Second run: 155 mg (73%). 
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 (3r,5r,7r)-1-(3-Isopropylphenyl)adamantane [183967-44-4] (eq 3).  The title compound was 
prepared according to general procedure C, using 1-iodoadamantane (262 mg, 1.0 mmol) and 
(1s,5s)-9-(3-isopropylphenyl)-9-borabicyclo[3.3.1]nonane (601 mg, 2.5 mmol).  Purification: 
Biotage, silica, 100% hexanes.  Colorless oil. 
First run: 158 mg (62%).  Second run: 150 mg (59%). 
 
 
Ph
 
Diphenylmethane [101-81-5] (eq 5).  This compound was prepared according to general 
procedure A (except that toluene was used in place of benzene), using 1-bromo-1-
methylcyclohexane (177 mg, 1.0 mmol) and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: 
Biotage, reverse-phase silica (C-18), 40% → 100% ACN/water, followed by Biotage, silica, 100% 
hexanes.  Colorless oil. 
First run: 48 mg (29%).  Second run: 53 mg (32%). 
1H NMR (300 MHz, CDCl3) ! 7.34–7.19 (m, 10H), 4.02 (s, 2H). 
13C NMR (100 MHz, CDCl3) ! 141.1, 128.9, 128.5, 126.1, 42.0. 
The direct cross-coupling product, (1-methylcyclohexyl)benzene, was also isolated using the 
aforementioned purification procedure. 
First run: 66 mg (38%). Second run: 72 mg (41%). 
 
 
Me
Ph
Ph  
(1-Methylcyclohexane-1,4-diyl)dibenzene (eq 6).  The title compound was prepared 
according to general procedure A, using ((1s,4s)-4-bromo-4-methylcyclohexyl)benzene (cis, dr 
>20:1; 253 mg, 1.0 mmol) and phenyl-(9-BBN) (495 mg, 2.5 mmol).  Purification: Biotage, 
reverse-phase silica (C-18), 40% → 100% acetonitrile/water.  White solid.  Isolated product is a 
mixture of diastereomers (1.2:1). 
First run: 181 mg (72%).  Second run: 185 mg (74%). 
1H NMR (300 MHz, CDCl3); diastereomer 1: ! 7.38–6.93 (m, 10H), 6.78–6.75 (m, 9H), 1.27 (s, 
3H). 
1H NMR (300 MHz, CDCl3); diastereomer 2: ! 7.38–6.93 (m, 10H), 6.78–6.75 (m, 9H), 1.09 (s, 
3H). 
13C NMR (100 MHz, CDCl3) ! 152.4, 147.44, 147.39, 147.2, 128.6, 128.5, 128.3, 127.0, 126.9, 
126.5, 126.1, 125.9, 125.7, 125.4, 125.2, 44.7, 44.2, 38.3, 38.09, 38.05, 36.6, 35.5, 30.6, 30.2, 24.5. 
FT-IR (film) 3085, 3058, 3025, 2928, 2857, 1943, 1869, 1800, 1602, 1581, 1494, 1450, 1376, 1098, 
1077, 1032, 1023, 964, 762 cm–1. 
MS (EI) m/z (M+) calcd for C19H22: 250, found: 250. 
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V.  Examples of Recalcitrant Aryl-(9-BBN) Coupling Partners 
 
yield (%)Ar
~20
<5
<5
<5
OMe
F
CF3
St -Bu
<5
Me
yield (%)Ar
<5
<5
15
<5
<5
Me
OMe
F
Me
Me
<5Ph
O
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